We also found that although most patients classified in AD3 subtype showed higher cytotoxic T‐cell infiltration and PD‐L1 gene overexpression (CD274), they were also unlikely to respond to ICI therapy according to TIDE scores (12% patients were classified as responders in AD3) [43]. Here, CD274 is linked to Alzheimer disease 3.